Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer

Cancer Cell

Volumn 3, Issue 5, 2003, Pages 449-458

  Forster, Alan ^a   Pannell, Richard ^a   Drynan, Lesley F ^a   McCormack, Matthew ^a   Collins, Emma C ^a,b   Daser, Angelika ^a   Rabbitts, Terence H ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b Becton Dickinson UK Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN; DNA BINDING PROTEIN; MLL ENL ONCOPROTEIN, HUMAN; MLL PROTEIN, HUMAN; MLL PROTEIN, MOUSE; MLL-ENL ONCOPROTEIN, HUMAN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CHROMOSOME 17; CHROMOSOME 9; GENETIC ENGINEERING; HUMAN; LEUKEMIA; LEUKEMOGENESIS; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION; REGULATORY MECHANISM; ALLELE; AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHROMOSOME; DISEASE MODEL; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TRANSLOCATION; GENETIC PROCEDURES; GENETIC RECOMBINATION; GENETICS; GENOTYPE; LEUKOCYTE; METABOLISM; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTO ONCOGENE; TIME; ULTRASTRUCTURE;

ANIMALIA;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHROMOSOMES; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENETIC TECHNIQUES; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKOCYTES; MICE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASMS; ONCOGENE PROTEINS, FUSION; PHENOTYPE; PROTO-ONCOGENES; RECOMBINATION, GENETIC; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0345582392     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00106-5     Document Type: Article

References (41)

1. Adams J.M., Harris A.W., Strasser A., Ogilvy S., Cory S. Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. Oncogene. 18:1999;5268-5277.
2. Ayton P.M., Cleary M.L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 20:2001;5695-5707.
3. Bain B.J. Leukemia diagnosis. A guide to the FAB classification: 1993;Wolfe Publishing, London.
4. Buchholz F., Refaeli Y., Trumpp A., Bishop J.M. Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. EMBO Rep. 1:2000;133-139.
5. Collins E.C., Rabbitts T.H. The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism. Trends Mol. Med. 8:2002;436-442.
6. Collins E.C., Pannell R., Simpson E.M., Forster A., Rabbitts T.H. Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development. EMBO Rep. 1:2000;127-132.
7. Corral J., Forster A., Thompson S., Lampert F., Kaneko Y., Slater R., Kroes W.G., van der Schoot C.E., Ludwig W.-D., Karpas A.et al. Acute leukemias of different lineages have similar MLL1 gene fusions encoding related chimeric proteins resulting from chromosomal translocations. Proc. Natl. Acad. Sci. USA. 90:1993;8538-8542.
8. Corral J., Lavenir I., Impey H., Warren A.J., Forster A., Larson T.A., Bell S., McKenzie A.N.J., King G., Rabbitts T.H. An Mll-Af9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice. A method to create fusion oncogenes Cell. 85:1996;853-861.
9. Djabali M., Selleri L., Parry P., Bower M., Young B.D., Evans G.A. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat. Genet. 2:1992;113-118.
10. Dobson C.L., Warren A.J., Pannell R., Forster A., Lavenir I., Corral J., Smith A.J.H., Rabbitts T.H. The Mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J. 18:1999;3564-3574.
11. Dobson C.L., Warren A.J., Pannell R., Forster A., Rabbitts T.H. Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene. EMBO J. 19:2000;843-851.
12. Domer P.H., Fakharzadeh S.S., Chen C.S., Jockel J., Johansen L., Silverman G.A., Kersey J.H., Korsmeyer S.J. Acute mixed-lineage t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc. Natl. Acad. Sci. USA. 90:1993;7884-7888.
13. Downing J.R., Shannon K.M. Acute leukemia. a pediatric perspective Cancer Cell. 2:2002;437-445.
14. Dutrillaux B. Chromosome alterations in human epithelial cancers. Adv. Cancer Res. 67:1998;59-82.
15. Feinberg A.P., Vogelstein B.A. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
16. Ford A., Ridge S., Cabrera M., Mahmoud H., Steel C., Chan L., Greaves M. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature. 27:1993;358-360.
17. Gu Y., Nakamura T., Alder H., Prasad R., Canaani O., Cimino G., Croce C.M., Canaani E. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell. 71:1992;701-708.
18. He L.Z., Tribioli C., Rivi R., Peruzzi D., Pelicci P.G., Soares V., Cattoretti G., Pandolfi P.P. Acute leukemia with promyelocytic features in PML/RARα transgenic mice. Proc. Natl. Acad. Sci. USA. 94:1997;5302-5307.
19. Higuchi M., O'Brien D., Kumaravelu P., Lenny N., Yeoh E.J., Downing J.R. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell. 1:2002;63-74.
20. Johnson K.A., Lerner C.P., Di Lacio L.C., Laird P.W., Sharpe A.H., Simpson E.M. Transgenic mice for the preparation of hygromycin-resistant primary embryonic fibroblasts feeder layers for embryonic stem cell selection. Nucleic Acids Res. 23:1995;1273-1275.
21. Karasuyama H., Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:1988;97-104.
22. Kogan S.C., Ward J.M., Anver M.R., Berman J.J., Brayton C., Cardiff R.D., Carter J.S., de Coronado S., Downing J.R., Fredrickson T.N.et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood. 100:2002;238-245.
23. Lavau C., Szilvassy S.J., Slany R., Cleary M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16:1997;4226-4237.
24. LeFranc M.-P., Forster A., Baer R., Stinson M.A., Rabbitts T.H. Diversity and rearrangement of the human T cell rearranging γ genes. Nine germ-line variable genes belonging to two subgroups Cell. 45:1986;237-246.
25. Linnell E.R., Lerner C.P., Johnson K.A., Leach C.A., Ulrich T.R., Rafferty W.C., Simpson E.M. Transgenic mice for the preparation of puromycin-resistant primary embryonic fibroblast feeder layers for embryonic stem cell selection. Mamm. Genome. 12:2001;169-171.
26. Look A.T. Oncogenic transcription factors in the human acute leukemias. Science. 278:1997;1059-1065.
27. Mitelman F., Johansson B., Mertens F. Mitelman Database of Chromosome Aberrations in Cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman:2000.
28. Okuda T., Cai Z., Yang S., Lenny N., Lyu C.J., van Deursen J.M., Harada H., Downing J.R. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood. 91:1998;3134-3143.
29. Pandolfi P.P. Knocking in and out genes and trans genes. the use of the engineered mouse to study normal and aberrant hemopoiesis Semin. Hematol. 35:1998;136-148.
30. Rabbitts T.H. Chromosomal translocations in human cancer. Nature. 372:1994;143-149.
31. Robertson E.J. Teratocarcinomas and Embryonic Stem Cells. A Practical Approach:1987;IRL Press, Oxford.
32. Rowley J.D. The critical role of chromosome translocations in human leukemias. Annu. Rev. Genet. 32:1998;495-519.
33. Schulte C.E., von Lindern M., Steinlein P., Beug H., Wiedemann L.M. MLL-ENL cooperates with SCF to transform primary avian multipotent cells. EMBO J. 21:2002;4297-4306.
34. Slany R.K., Lavau C., Cleary M.L. The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX. Mol. Cell. Biol. 18:1998;122-129.
35. Smith A.J.H., De Sousa M.A., Kwabi-Addo B., Heppell-Parton A., Impey H., Rabbitts P.H. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nat. Genet. 9:1995;376-384.
36. Thirman M.J., Gill H.J., Burnett R.C., Mbangkollo D., McCabe N.R., Kobayashi H., Ziemin-van der Poel S., Kaneko Y., Morgan R., Sandberg A.A.et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N. Engl. J. Med. 329:1993;909-914.
37. Tkachuk D.C., Kohler S., Cleary M.L. Involvement of a homolog of Drosophila Trithorax by 11q23 chromosomal translocations in acute leukemias. Cell. 71:1992;691-700.
38. van Deursen J., Fornerod M., van Rees B., Grosveld G. Cre-mediated site-specific translocation between nonhomologous mouse chromosomes. Proc. Natl. Acad. Sci. USA. 92:1995;7376-7380.
39. Warren A.J., Colledge W.H., Carlton M.B.L., Evans M.J., Smith A.J.H., Rabbitts T.H. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell. 78:1994;45-58.
40. Yamada Y., Warren A.W., Dobson C., Forster A., Pannell R., Rabbitts T.H. The T cell leukaemia LIM protein Lmo2 is necessary for adult mouse haematopoiesis. Proc. Natl. Acad. Sci. USA. 95:1998;3890-3895.
41. Yergeau D.A., Hetherington C.J., Wang Q., Zhang P., Sharpe A.H., Binder M., Marin-Padilla M., Tenen D.G., Speck N.A., Zhang D.E. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15:1997;303-306.